A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication

Molecular Therapy

Volumn 14, Issue 2, 2006, Pages 268-275

  Westerhout, Ellen M ^a   Vink, Monique ^a   Joost Haasnoot, P C ^a   Das, Atze T ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

HIV 1; live attenuated vaccine; replicating viral vector; RNAi therapy

Indexed keywords

DOXYCYCLINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VIRUS VECTOR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; DRUG WITHDRAWAL; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; INHIBITION KINETICS; PROVIRUS; RNA INTERFERENCE; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; VIRUS VIRULENCE;

CELL LINE, TUMOR; DOXYCYCLINE; GENE PRODUCTS, NEF; GENES, NEF; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRANSFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745384405     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.03.018     Document Type: Article

References (29)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
2. Hammond S.M., Bernstein E., Beach D., and Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404 (2000) 293-296
3. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
4. Zamore P.D., Tuschl T., Sharp P.A., and Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101 (2000) 25-33
5. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
6. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
7. Paul C.P., Good P.D., Winer I., and Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20 (2002) 505-508
8. Das A.T., et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78 (2004) 2601-2605
9. Westerhout E.M., Ooms M., Vink M., Das A.T., and Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 33 (2005) 796-804
10. Verhoef K., Marzio G., Hillen W., Bujard H., and Berkhout B. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J. Virol. 75 (2001) 979-987
11. Berkhout B., Marzio G., and Verhoef K. Control over HIV-1 replication by an antibiotic: a novel vaccination strategy with a drug-dependent virus. Virus Res. 82 (2002) 103-108
12. Baron U., and Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol. 327 (2000) 401-421
13. Marzio G., Verhoef K., Vink M., and Berkhout B. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc. Natl. Acad. Sci. USA 98 (2001) 6342-6347
14. Marzio G., Vink M., Verhoef K., de Ronde A., and Berkhout B. Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription. J. Virol. 76 (2002) 3084-3088
15. Das A.T., et al. Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J. Biol. Chem. 279 (2004) 18776-18782
16. Kiselyeva Y., et al. Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1. Virology 328 (2004) 1-6
17. Klaver B., and Berkhout B. Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J. Virol. 68 (1994) 3830-3840
18. Nethe M., Berkhout B., and van der Kuyl A.C. Retroviral superinfection resistance. Retrovirology 2 (2005) 52
19. Berkhout B. RNA interference as an antiviral approach: targeting HIV-1. Curr. Opin. Mol. Ther. 6 (2004) 141-145
20. Almond N., Kent K., Cranage M., Rud E., Clarke B., and Stott E.J. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345 (1995) 1342-1344
21. Baba T.W., et al. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5 (1999) 194-203
22. Das A.T., Baldwin C.E., Vink M., and Berkhout B. Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry. J. Virol. 79 (2005) 3855-3858
23. Baldwin C.E., et al. Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor. J. Virol. 78 (2004) 12428-12437
24. Unwalla H.J., et al. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nat. Biotechnol. 22 (2004) 1573-1578
25. Back N.K.T., et al. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15 (1996) 4040-4049
26. Brummelkamp T.R., Bernards R., and Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2 (2002) 243-247
27. Das A.T., Verhoef K., and Berkhout B. A conditionally replicating virus as a novel approach toward an HIV vaccine. Methods Enzymol. 388 (2004) 359-379
28. ELI. Virology 185 (1991) 661-672
29. Jacque J.M., Triques K., and Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 418 (2002) 435-438